S
Spero Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2013 · IPO 2017
Investors
13 investors on Spero Therapeutics's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Spero Therapeutics mafia
Startups founded by Spero Therapeutics alumni
Former Spero Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.
Global footprint
Where Spero Therapeutics has talent and traffic
Talent graph
The shape of Spero Therapeutics's talent
Dealroom maps Spero Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Market sentiment
What the market is saying about Spero Therapeutics
An AI-synthesized read of the highest-engagement posts about Spero Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Spero Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.